Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-03-000433
Filing Date
2003-02-14
Accepted
2003-02-14 12:03:36
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sc13ga_021203-arqule.txt SC 13G/A 8563
3 JOINT FILING AGREEMENT ex1-1_021203arqule.txt EX-1.1 2078
4 STATEMENT O CONTROL PERSON ex2-1_021203arqule.txt EX-2.1 736
  Complete submission text file 0000947871-03-000433.txt   13544
Mailing Address 19 PRESIDENTIAL WAY WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY WOBURN MA 01801 6173954100
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

EIN.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48819 | Film No.: 03564354
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE